# Enoxaparin as Treatment for Vulvodynia

> **NCT00874484** · PHASE2 · COMPLETED · sponsor: **Western Galilee Hospital-Nahariya** · enrollment: 40 (estimated)

## Conditions studied

- Vulvodynia

## Interventions

- **DRUG:** Clexane (enoxaparin)

## Key facts

- **NCT ID:** NCT00874484
- **Lead sponsor:** Western Galilee Hospital-Nahariya
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-05
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00874484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00874484, "Enoxaparin as Treatment for Vulvodynia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00874484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*